All updates
All updates
today 28文献与产业新闻精选评分6464 文献与产业新闻评分4747 Aurobindo unit, China API maker dinged in latest round of FDA warning letters
文献与产业新闻精选评分6262 Pick of Trump loyalist Overton revives questions of FDA independence
文献与产业新闻评分2323 Physician group sues Trump administration over dietary guidelines process
文献与产业新闻评分3939 STAT+: Trump expected to pick White House adviser Heidi Overton to lead FDA
文献与产业新闻精选评分6363 Trump administration sued over visa time limit that would affect grad students, postdocs
文献与产业新闻评分5454 Teva scores rare partial win in CMS price negotiation appeal
文献与产业新闻评分2424 STAT+: Government workers feel the squeeze on health care
文献与产业新闻评分3232 MHRA advises against the use of rectal catheters in infants
中文产业新闻Chinese source评分6060 FDA批准Lantheus靶向Tau的PET示踪剂TAUKLARIFY用于阿尔茨海默病评估
中文产业新闻Chinese source评分6161 国家医保局按病种付费3.0版首批158个基层病种将实行同病同付
中文产业新闻Chinese source评分6464 国家医保局首次遴选158个基层病种实施「同病同付」，按病种付费3.0版分组方案即将印发
中文产业新闻精选Chinese source评分6868 先通医药合作伙伴Lantheus的Tau PET示踪剂TAUKLARIFY获FDA批准上市
文献与产业新闻精选评分7575 Regeneron's Pasatru scores FDA approval in ultra-rare bone lesions disorder
FDA Press Releases评分3636 FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
文献与产业新闻评分4343 MHRA sets out position on regulation of microbiome-based medicinal products
文献与产业新闻评分4545 Celcuity keeps cool amid questions about Revtorpyk launch timing
顶刊论文（社媒热度）精选评分6060 FDA Approves Gene Therapy for Younger Children With Sickle Cell Disease.
文献与产业新闻评分2323 Johnson & Johnson MedTech nabs Monarch Quest 3 update for lung cancer detection
文献与产业新闻评分4444 U.S. aims to slash pre-IND timelines: Back to School 2026
中文产业新闻Chinese source评分6666 默沙东口服PCSK9抑制剂Lipfendra获FDA批准，市场对降脂赛道反应分化
中文产业新闻精选Chinese source评分7171 睿笛生物SPA-C02陡脉冲消融仪获FDA批准，完成中欧美三大市场认证
中文产业新闻Chinese source评分6161 国家医保局：医保基金即时结算改革目标提前完成，双双突破90%
中文产业新闻Chinese source评分6666 T-DXd+P正式获NMPA批准，用于HER2阳性晚期乳腺癌一线治疗
中文产业新闻Chinese source评分6363 NMPA批准安罗替尼用于晚期鳞状非小细胞肺癌一线治疗，依据ETER700Ⅲ期结果
文献与产业新闻评分4040 Everything the Trump administration did on health care last week
文献与产业新闻评分4343 STAT+: Kennedy’s split-screen week: Talk of vaccines in D.C., fraud and addiction out West
文献与产业新闻评分5252 FDA clears Lantheus’ Alzheimer’s PET imaging agent Tauklarify
中文产业新闻精选Chinese source评分7676 基于 MRD 阴性终点，FDA 批准 BMS 蛋白降解剂 Iberdomide 上市
文献与产业新闻评分5050 Will Capricor’s latest move give deramiocel new life?
中文产业新闻精选Chinese source评分7575 FDA加速批准首个CELMoD药物iberdomide联合方案治疗多发性骨髓瘤
中文产业新闻精选Chinese source评分7979 Arvinas与辉瑞的PROTAC vepdegestrant获FDA批准，成为首个获批的PROTAC
中文产业新闻Chinese source评分6666 天境生物与渤健联合宣布CD38抗体菲泽妥单抗在中国获批，系该产品全球范围内首个获批的适应症
中文产业新闻Chinese source评分6262 辉瑞与 Valneva 的莱姆病候选疫苗 PF-07307405 获 EMA 受理上市申请
中文产业新闻精选Chinese source评分7575 百时美施贵宝Iberdomide获FDA批准用于复发或难治性多发性骨髓瘤
中文产业新闻Chinese source评分6565 Tinlarebant治疗STGD1的上市申请获FDA优先审评
中文产业新闻Chinese source评分6565 恒瑞医药舒地胰岛素注射液获NMPA批准上市，成中国首个自研长效胰岛素类似物
中文产业新闻精选Chinese source评分7676 百时美施贵宝Iberdomide获FDA加速批准，成首款获FDA批准的CELMoD类药物
中文产业新闻精选Chinese source评分7171 BMS 多发性骨髓瘤新药 iberdomide 获 FDA 批准，为 CELMoD 机制首个获批药物
中文产业新闻Chinese source评分6363 天境生物与渤健宣布菲泽妥单抗在中国获批上市，为该产品全球首次获批